Product Information
SANDOSTATIN LAR DEPOT 30 MG KT is a brand product labeled by Novartis Pharmaceuticals Corporation, priced at $6680.8500 per EA under NDC 00078082581. Its NADAC has been published 45 times since Aug 20, 2025.
The High Outlier badge above means this manufacturer's average price in the octreotide acetate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Manufacturer
Novartis Pharmaceuticals CorporationNDC
00078082581
Classification
Brand
Dosage Form
KIT
Last Updated
2/18/2026
Approval Type
New Drug (NDA)
FDA Application
NDA021008On Market Since
7/22/2016
Price Statistics
The NADAC for SANDOSTATIN LAR DEPOT 30 MG KT has been published 45 times since Aug 20, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $6680.8500 per EA |
|---|---|
| All-time high | $6680.8500 (Jun 24, 2026) |
| All-time low | $6635.6400 (Nov 19, 2025) |
| 52-week high | $6680.8500 |
| 52-week low | $6635.6400 |
| Median price | $6680.8500 |
| Average price | $6673.4679 |
| Largest weekly change | +0.7% (Dec 17, 2025) |
| Weeks tracked | 45 |
| Tracking since | Aug 20, 2025 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 49% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of SANDOSTATIN LAR DEPOT 30 MG KT?
The current National Average Drug Acquisition Cost (NADAC) for SANDOSTATIN LAR DEPOT 30 MG KT, manufactured by Novartis Pharmaceuticals Corporation, is $6680.8500 per EA (NDC 00078082581), effective Jun 24, 2026.
How has the price of SANDOSTATIN LAR DEPOT 30 MG KT changed over time?
Over the history we have for it, the NADAC for SANDOSTATIN LAR DEPOT 30 MG KT has held within roughly two percent of its current level. It has been tracked across 45 weekly CMS publications since Aug 20, 2025.
What are the highest and lowest recorded NADAC prices for SANDOSTATIN LAR DEPOT 30 MG KT?
Since Aug 20, 2025, the NADAC for SANDOSTATIN LAR DEPOT 30 MG KT has ranged from a low of $6635.6400 (Nov 19, 2025) to a high of $6680.8500 (Jun 24, 2026), with a median of $6680.8500 per EA.
Are there cheaper alternatives to SANDOSTATIN LAR DEPOT 30 MG KT?
Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, SANDOSTATIN LAR DEPOT 10 MG KT, is $3387.5280 per EA — about 49% below SANDOSTATIN LAR DEPOT 30 MG KT.
Who manufactures SANDOSTATIN LAR DEPOT 30 MG KT?
SANDOSTATIN LAR DEPOT 30 MG KT (NDC 00078082581) is labeled by Novartis Pharmaceuticals Corporation, and CMS classifies it as a brand product.
Related Drugs
Same classification